Fractalkine (CX3CL1): a biomarker reflecting symptomatic severity in patients with knee osteoarthritis. (Q50584701)
Jump to navigation
Jump to search
scientific article published in April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fractalkine (CX3CL1): a biomarker reflecting symptomatic severity in patients with knee osteoarthritis. |
scientific article published in April 2015 |
Statements
1 reference
Fractalkine (CX3CL1): a biomarker reflecting symptomatic severity in patients with knee osteoarthritis. (English)
1 reference
Li Wei Huo
1 reference
Yong Liang Ye
1 reference
Guang Wei Wang
1 reference
Yong Guang Ye
1 reference
1 April 2015
1 reference
63
1 reference
4
1 reference
626-631
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference